Cancer genetics clinics: Target population and consultees' expectations

European Journal of Cancer

Volumn 32, Issue 3, 1996, Pages 398-403

  Julian Reynier, C ^a   Eisinger, F ^a,b   Chabal, F ^a   Aurran, Y ^a   Nogues C ^c   Vennin, P ^d   Bignon, Y J ^e   Machelard Roumagnac, M ^f   Maugard Louboutin, C ^g   Serin, D ^h   Versini, S ⁱ   Mercuri, M ^j   Sobol, H ^a,b  

^a INSERM   (France)

^b INSTITUT PAOLI CALMETTES   (France)

^c CENTRE RENÉ HUGUENIN   (France)

^d CENTRE OSCAR LAMBRET   (France)

^e CENTRE JEAN PERRIN   (France)

^f INSTITUT CLAUDIUS REGAUD   (France)

^g CENTRE RENÉ GAUDUCHEAU   (France)

^h INSTITUT SAINTE CATHERINE   (France)

ⁱ Hôpital de la Misericorde   (France)

^j Mutuelles de Provence   (France)

more..

Author keywords

Cancer; Clinical genetics; Consultees; Counselling; Social epidemiology

Indexed keywords

ARTICLE; CANCER GENETICS; CANCER RISK; FEMALE; GENETIC COUNSELING; HUMAN; MALE; NORMAL HUMAN; PERCEPTION; PRIORITY JOURNAL; QUESTIONNAIRE;

ADULT; FEMALE; FRANCE; GENETICS, MEDICAL; HUMANS; MALE; MEDICAL ONCOLOGY; OUTPATIENT CLINICS, HOSPITAL; PATIENTS; REFERRAL AND CONSULTATION; RISK ASSESSMENT; SOCIOECONOMIC FACTORS;

EID: 0029972696     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00601-X     Document Type: Article

References (30)

1. Hoskins IA. Genetic counseling for cancer patients and their families. Oncology 1989, 3, 84-92.
2. Houlston RS, Murday V, Harocopos C, Williams CB, Slack J. Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic. Br Med J 1990, 301, 366-368.
3. Sobol H, Mazoyer S, Narod S, et al. Genetic heterogeneity of early-onset familial breast cancer. Hum Genet 1992, 89, 381-383.
4. Hodgson SV, Maher ER. A Practical Guide to Human Cancer Genetics. Cambridge, Cambridge University Press, 1993.
5. Evans DGR, Blair V, Greenhalgh P, Hopwood P, Howell A. The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br J Cancer 1994, 70, 934-938.
6. Lerman C, Lustbader E, Rimer B, et al. Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst 1995, 87, 286-292.
7. Sobol H, Bignon Y-J, Cuisenier J, Lyonnet D, Noguès C, Eisinger F, et le groupe Génétique et Cancer de la FNCLCC. Le groupe Génétique et Cancer de la FNCLCC. Les consultations d'oncogénétique en 1994, analyse de l'activité: enquête sur 203 consultations. In Boiron M, ed. Eurocancer 95. Paris, John Libbey Eurotext, 1995, 43-46.
8. Kash KM, Holland JC, Halper MS, Miller G. Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 1992, 84, 24-30.
9. Vernon SW, Vogel VG, Halabi S, Bondy ML. Factors associated with perceived risk of breast cancer among women attending a screening program. Breast Cancer Res Treat 1993, 28, 137-144.
10. Green J, Murton F, Statham H. Psychosocial issues raised by a familial ovarian cancer register. J Med Genet 1993, 30, 575-579.
11. Vasen HFA. Screening in breast cancer families: is it useful? Ann Med 1994, 26, 185-190.
12. Bostick RM, Sprafka JM, Virnig BA, Potter JD. Knowledge, attitudes, and personal practices regarding prevention and early detection of cancer. Prev Med 1993, 22, 65-85.
13. Evers-Kiebooms G, Van Den Berghe H. Impact of genetic counseling: a review of published follow-up studies. Clin Genet 1979, 15, 465-474.
14. Wertz DC, Sorenson JR, Heeren TC. Clients' interpretation of risks provided in genetic counseling. Am J Hum Genet 1986, 39, 253-264.
15. Shiloh S, Sagi M. Effects of framing on the perception of genetic recurrence risks. Am J Med Genet 1989, 33, 130-135.
16. Sorenson JR, Wertz DC. Couple agreement before and after genetic counseling. Am J Med Genet 1986, 25, 549-555.
17. Wertz D, Fletcher JC. Interpretation of genetic and environmental risks. Sci Technol Hum Values 1987, 12 (3/4), 60-66.
18. Edwards AWF. Probability and likelihood in genetic counselling. Clin Genet 1989, 36, 209-216.
19. Weinstein ND. Optimistic biases about personal risks. Science 1989, 240, 1232-1233.
20. Gochman DS. Health Behavior: Emerging Research Perspectives. New York, Plenum Press, 1988.
21. Weinstein ND. Why it won't happen to me: perceptions of risk factors and susceptibility. Health Psychol 1984, 3, 431-457.
22. Miki Y, Swenson J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266, 66-71.
23. Futréal P, Liu Q, Shattuck-Eidens D, et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994, 266, 120-122.
24. Fishel R, Kolodner RD. Identification of mismatch repair genes and their role in the development of cancer. Curr Opin Genet Dev 1995, 5, 382-395.
25. Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994, 12, 843-850.
26. Hietala MHAA, Arja R, Niemela P, Peltonen L, Aula P. Attitudes toward genetic testing among the general population and relatives of patients with a severe genetic disease: a survey from Finland. Am J Hum Genet 1995, 56, 1493-1500.
27. Lippman-Hand A, Fraser FC. Genetic counseling: parents' responses to uncertainty. Birth Defect 1979, 15, 5C, 325-339.
28. Nayfield SG, Karp JE, Ford LG, Dorr FA, Kramer BS. Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst 1991, 83, 20, 1450-1459.
29. Mulvihill JJ, Safyer AW, Bening JK. Prevention in familial breast cancer: counseling and prophylactic mastectomy. Prev Med 1982, 11, 500-511.
30. Vogel VG, Yeomans A, Higginbotham E. Clinical management of women at increased risk for breast cancer. Breast Cancer Res Treat 1993, 28, 195-210.